Preparation, characterization, and measurement of lipoprotein lipase.
P H Iverius, A M Ostlund-Lindqvist
https://pubmed.ncbi.nlm.nih.gov/3523161Actively Recruiting
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2026-06-08
2000
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to better understand dyslipidemias, which are disorders affecting the fat content in the blood. These fat particles, known as lipoproteins, carry cholesterol and triglycerides in the bloodstream and play a role in diseases like atherosclerosis and heart attack. The study focuses on patients with unusual lipid levels or deposits, including both very high and very low cholesterol or triglyceride levels, and aims to evaluate potential genetic defects affecting lipid metabolism. Participants will undergo a thorough plasma evaluation including specialized tests for lipids, lipoproteins, apolipoproteins, enzymes, and receptors involved in lipid metabolism. These advanced tests go beyond standard clinical assays to help diagnose and guide treatment for patients with rare or complex lipid disorders. The study includes patients referred from various medical sources and covers a wide range of lipid abnormalities and related clinical signs. During the study, participants will have blood samples taken for detailed analysis of their lipid profiles and related proteins. Researchers will review these measurements to accurately diagnose and understand the participants' conditions over a period of up to 25 years. This long-term observation will help identify genetic factors and natural history of lipid disorders, supporting better diagnosis and treatment strategies. Participants are monitored through accepted medical tests and procedures throughout the study.
CONDITIONS
Causes and Natural History of Dyslipidemias
You may qualify if you...
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Ongoing as needed
Participants undergo specialized plasma assays and evaluations to diagnose potential genetic defects in lipid metabolism.
1 or more visits depending on diagnostic requirements
Duration - Up to 25 years
Participants are observed over time to monitor lipoprotein levels and clinical manifestations associated with dyslipoproteinemias.
Periodic visits as scheduled by the study team
Total: 1 location
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
R
Robert D Shamburek, M.D.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
P H Iverius, A M Ostlund-Lindqvist
https://pubmed.ncbi.nlm.nih.gov/3523161S Santamarina-Fojo, H B Brewer
https://pubmed.ncbi.nlm.nih.gov/1992190A Chait, P H Iverius, J D Brunzell
https://pubmed.ncbi.nlm.nih.gov/7056857